And researchers warn that warned that even low-to-moderate drinking carries measurable risks across cancer, cardiovascular disease, dementia and liver disease.
A sweeping review has reinforced alcohol’s role in driving a broad spectrum of disease, linking consumption to at least 62 fully conditions and harmful effects across cancers, cardiovascular disease, liver disease, dementia and other injuries.
And researchers have warned that even low-to-moderate drinking carries measurable health risks across multiple body systems.
Fully alcohol-attributable conditions were identified using International Classification of Diseases (ICD) 10th and 11th revision codes in the scoping review of meta-analyses of cohort studies on average consumption and health outcomes (56 reviews), a systematic review of Mendelian randomisation (MR) studies on alcohol and ischaemic heart disease (20 studies), and narrative syntheses on injuries, biological pathways and reversibility of effects.
“Meta-analyses support monotonic increasing dose–response relationships between average consumption and most attributable health outcomes within infectious diseases, cardiovascular diseases, cancers and digestive diseases,” the researchers wrote.
But there was some good news.
“Acute risks are reversible with reductions in drinking or abstention, whereas many chronic disease processes are only partly reversible,” the researchers wrote.
The review, published in Addiction, revealed analysis using the 11th revision of the International Classification of Diseases codes recognised 62 conditions fully attributable to alcohol, up from 48 under ICD-10, reflecting growing evidence of alcohol’s role in disease burden.
The updated analysis examined evidence across infectious disease, cancer, cardiovascular disease, diabetes, neuropsychiatric disease, gastrointestinal disease and injury.
The paper found monotonic dose-response relationships for most alcohol-related conditions, meaning risk generally rose as consumption increased. This was particularly consistent for infectious diseases, digestive disease and multiple cancers, including breast, liver, colorectal, oesophageal and oral cancers.
Alcohol was described as a “major carcinogen”, ranking among the leading preventable causes of cancer in many countries.
The researchers pointed to acetaldehyde-induced DNA damage, oxidative stress, inflammation and hormonal disruption as key biological pathways underpinning carcinogenesis.
They noted that alcohol-related harm extended beyond chronic disease. Injury risk was found to be strongly driven by acute intoxication, with alcohol contributing to road trauma, falls, burns, drowning, poisoning, violence and self-harm.
Blood alcohol concentrations as low as 0.03 g/dL could impair reaction time and executive function, they reported.
The researchers also highlighted the potential harms to people other than the drinker, particularly through intimate partner violence, sexual assault and road traffic injuries. ICD-11 now includes diagnostic categories recognising alcohol-related harm to others.
While the review reaffirmed harmful effects across most disease categories, it also revisited the long-running debate around low-level drinking and cardiovascular disease.
Cohort studies continued to support J-shaped associations for ischaemic heart disease (IHD), ischaemic stroke and type 2 diabetes, where low-to-moderate alcohol intake appeared associated with lower risk compared with abstinence, provided heavy episodic drinking was absent.
However, MR evidence was less supportive of a cardioprotective effect, with many studies showing null or harmful associations.
“In our view, the overall synthesis indicates that current MR evidence is insufficient to refute a J-shaped relationship for IHD,” the researchers wrote.
The picture was a lot clearer for gastrointestinal diseases, they said.
“Establishing the causal impact of alcohol consumption on both liver cirrhosis and pancreatitis is not necessary, because both conditions include subtypes that are fully attributable to alcohol by definition,” they wrote.
“However, it is important to note that alcohol consumption also affects the progression of both disease categories, independent of the original aetiology. For instance, a recent meta-analysis found that approximately 40% of all complications related to liver disease caused by hepatitis C (i.e. liver cirrhosis, decompensated liver cirrhosis and death) could be attributable to heavy drinking.
“For any global [comparative risk assessment], this implies that relative risk functions should be applied to all liver cirrhosis outcomes, irrespective of the original aetiology.”
Related
It was a similar picture with cancers. The International Agency for Research on Cancer (IARC) determined in 2010 and 2012 that alcohol consumption causally impacts seven cancer sites, which have been included in all comparative risk assessments (CRAs).
“Although the causal impact of alcohol on all seven cancer sites determined by IARC has been confirmed in recent reviews and meta-analyses, there are clear indications that additional cancer sites may also be causally impacted by alcohol consumption: first, several meta-analyses find stable dose–response relationships between alcohol and cancers of the stomach, biliary tract, pancreas and lung, although the risk for lung cancer almost disappeared when estimated in never smokers,” the researchers wrote.
“Moreover, large hospital-based cohort studies found stable and harmful associations between alcohol dependence and these additional cancer sites, as well as a reduction of risk for these cancer sites after alcohol treatment interventions.
“At this point, only the systematic evaluation of causality by IARC is needed to decide which cancer sites should be included in CRAs for alcohol, and it should be undertaken urgently for all sites with stable epidemiological associations that have not yet been included.”
The researchers also highlighted growing evidence linking heavy alcohol use to dementia.
Alcohol dependence was associated with a threefold increase in dementia risk in some large population studies, with alcohol-related dementia risk exceeding that of other established modifiable risk factors identified by The Lancet Commission.
For liver disease, the review reinforced alcohol’s central role in cirrhosis progression regardless of the original cause. Researchers cited evidence suggesting around 40% of hepatitis C-related liver complications could be attributable to heavy drinking.
They said alcohol epidemiology still faced substantial methodological challenges, including inaccurate self-reporting, poorly characterised drinking patterns and time-varying alcohol exposure.
They called for more sophisticated cohort studies, greater use of target trial emulation and better integration of genetic and observational evidence.
“The field of alcohol epidemiology can make substantial progress by refining its approaches and methods to provide clearer answers on the causal effects of alcohol consumption on health outcomes, the reversibility of those effects and the resulting alcohol-attributable burden, all of which are central for designing effective interventions,” they concluded.
“Many of our studies on alcohol consumption and health are still plagued by the same problems that were pointed out 20 years ago – even though they are, in principle, avoidable.”
